Recombinant Anti-CD274 Antibody (V3S-0622-YC74) (CAT#: V3S-0622-YC74)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody that specifically binds to PD-L1. The antibody can be useful for detecting the expression of human programmed death ligand-1 (PD-L1) in tumor tissue sections by immunohistochemial assay. The antibody can block binding of PD-L1 to PD-1 and has anti-tumor activity against a variety of tumor types.
Clonality Monoclonal
Host Species Mouse
Target Species Human
Isotype IgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein G affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application IHC
Application Notes The antibody is recommended for detection of CD274 by IHC (1/20-1/200) assay.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CD274
Alternative Name B7-H; B7H1; PDL1; PD-L1; hPD-L1; PDCD1L1; PDCD1LG1; programmed cell death 1 ligand 1; B7 homolog 1; CD274 antigen; PDCD1 ligand 1
Gene ID 29126
UniProt Q9NZQ7
Research Area Immunology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry